Investigating human metabolome in infectious disease, microbiota and cancer

Keyphrases

• Metabolomics 100%
• Microbiota 100%
• Infectious Diseases 100%
• Virus-associated Cancer 100%
• Human Metabolome 100%
• Cancer Tissue 66%
• COVID-19 66%
• Feces 66%
• Adenomatous Polyps 66%
• Metabolomics Study 66%
• Metabolic Signature 66%
• Virus 33%
• Small Molecules 33%
• Gut Microbiota 33%
• Potential Biomarkers 33%
• Aggressiveness 33%
• Infected Patients 33%
• Pediatric 33%
• Obese Patients 33%
• Plasma Samples 33%
• Noninvasive Diagnostic Method 33%
• Mediterranean Diet 33%
• Metabolic Phenotype 33%
• Host Response 33%
• Sarcoma 33%
• Extraction Methods 33%
• Dietary Intervention 33%
• Healthy Food 33%
• Healthy Tissue 33%
• Potential Diagnostic Markers 33%
• Short-chain Fatty Acids 33%
• Fecal Samples 33%
• SARS-CoV-2 Infection 33%
• COVID-19 Patients 33%
• COVID-19 Infection 33%
• GC × GC-TOFMS 33%
• Metabolomics Methods 33%
• Protective Metabolites 33%
• Osteosarcoma Cancer 33%

Biochemistry, Genetics and Molecular Biology

• Metabolomics 100%
• Microflora 100%
• Metabolome 100%
• SARS Coronavirus 60%
• Biochemistry 40%
• Metabolite 40%
• Blood Plasma 40%
• Small Molecule 20%
• Immune Response 20%
• Time-of-Flight Mass Spectrometry 20%
• Intestine Flora 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Infection 100%
• Microflora 100%
• SARS Coronavirus 60%
• Adenomatous Polyp 40%
• Connective Tissue Cancer 40%
• Diseases 40%
• Biological Marker 20%
• Intestine Flora 20%
• Disease Predisposition 20%